The effects of bortezomib on bone disease in patients with multiple myeloma

E-ISSN： 1097-0142|120|5|618-623

ISSN： 0008-543x

Source： CANCER, Vol.120, Iss.5, 2014-03, pp. : 618-623

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Anti-Angiogenic Effect of Bortezomib in Patients with Multiple Myeloma

Acta Haematologica, Vol. 114, Iss. 3, 2005-10 ,pp. : 170-173

Karger

Access to resources Recommend Favorite

The Impact of Mast Cell Density on the Progression of Bone Disease in Multiple Myeloma Patients

International Archives of Allergy and Immunology, Vol. 168, Iss. 4, 2016-02 ,pp. : 263-268

Karger

Access to resources Recommend Favorite

Unusual Discordant Responses in Two Multiple Myeloma Patients during Bortezomib Treatment

Oncology Research and Treatment, Vol. 31, Iss. 1-2, 2008-01 ,pp. : 45-47

Karger

Access to resources Recommend Favorite

Bortezomib Administered Subcutaneously Is Well Tolerated in Bortezomib-Based Combination Regimens Used in Patients with Multiple Myeloma

Oncology, Vol. 85, Iss. 4, 2013-09 ,pp. : 223-227

Karger

Access to resources Recommend Favorite

Effect of cumulative bortezomib dose on survival in multiple myeloma patients receiving bortezomib‐melphalan‐prednisone in the phase III VISTA study

AMERICAN JOURNAL OF HEMATOLOGY, Vol. 90, Iss. 4, 2015-04 ,pp. : 314-319

John Wiley & Sons Inc

Access to resources Recommend Favorite